Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

Go back to Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 222.85 -2.15 (0.96%)
Previous Close $225.00    52 Week High $0.52 
Open $224.50    52 Week Low $0.08 
Day High $227.46    P/E N/A 
Day Low $218.51    EPS $-3.80 
Volume 5,190,244